Cyclosporin A generates superoxide in smooth muscle cells

References

• Bore JF, Baumann G, Chapman I, Donatsch P, Fahr A, Mueller EA, Vigouret JM. In vivo pharmacological effects of ciclosporin and some analogues. Adv Pharmacol 1996;35:115–246.
   PubMedGoogle Scholar
• Mason J. Pharmacology of cyclosporine (sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol Rev 1990;41:423–434.
   Google Scholar
• Textor SC, Canzanello VJ, Taler SJ, Wilson DJ, Schwartz LL, Augustine JE, Raymer JM, Romero JC, Wiesner RH, Krom RA. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 1994;69:1182–1193.
   PubMed Web of Science ®Google Scholar
• Xue H, Bukoski RD, McCarron DA, Bennett WM. Induction of contraction in isolated rat aorta by cyclosporine. Trans-plantation 1987;43:715–718.
   Google Scholar
• Lamb FS, Webb RC. Cyclosporine augments reactivity of isolated blood vessels. Life Sci 1987;40:2571–2578.
   PubMed Web of Science ®Google Scholar
• Curtis JJ, Luke RG, Dubovsky E, Diethelm AG, Whelchel JD, Jones P. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986;2:477–479.
   PubMed Web of Science ®Google Scholar
• Pfeilschifter J, Ruegg UT. Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J 1987;248:883–887.
   PubMed Web of Science ®Google Scholar
• Rossi NF, Churchill PC, McDonald FD, Ellis VR. Mechanism of cyclosporin A-induced renal vasoconstriction in the rat. J Pharmacol Exp Ther 1989;250:896–901.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Puyol D, Lamas S, Olivera A, Lopez-Farre A, Ortega G, Hernando L, Lopez-Novoa JM. Actions of cyclosporin A on cultured rat mesangial cells. Kidney Int 1989;35:632–637.
   Google Scholar
• Radermacher J, Meiners M, Bramlage C, Kliem V, Behrend M, Schlitt HJ, Pichlmayr R, Koch KIVI, Brunkhorst R. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. Transplant Int 1998;11: 3–10.
   Google Scholar
• Meyer-Lehnert H, Schrier RW. Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction. Hypertension 1989;13:352–360.
   Google Scholar
• Locher R, Huss R, Vetter W. Potentiation of vascular smooth muscle cell activity by cyclosporin A. Eur J Clin Pharmacol 1991;41:297–301.
   Google Scholar
• Lo Russo A, Passaquin AC, André P, Skutella M, Ruegg UT. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immuno-suppressive activity. Br J Pharmacol 1996;118:885–892.
   Google Scholar
• Bagnis C, Deray G. Calcium inhibitors in the management of hypertensive patients on cyclosporine. Arch Malad Coeur Vaisseaux 1998;91:411–414.
   PubMedGoogle Scholar
• Iwasaki S, Homma T, Kon V. Site specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporine. Kidney Int 1994;45:592–597.
   Google Scholar
• Regitz-Zagrosek V, Auch-Schwelk W, Hess B, Klein U, Duske E, Steffen C, Hildebrandt AG, Fleck E. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin- converting enzyme inhibitors and AT1 antagonists. J Cardiovasc Pharmacol 1995;26:66–72.
   PubMedGoogle Scholar
• Iwai J, Kanayama Y, Negoro N, Okamura M, Takeda T. Gene expression of endothelin receptors in aortic cells from cyclosporine-induced hypertensive rats. Clin Exp Pharmacol Physiol 1995;22:404–409.
   Google Scholar
• Lo Russo A, Passaquin AC, Cox C, Ruegg UT. Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Rec Signal Transd Res 1997;17:149–161.
   PubMed Web of Science ®Google Scholar
• Avdonin PV, Cottet-Maire F, Afanasjeva GV, Loktionova SA, Lhote P, Ruegg UT. Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells. Kidney Int 1999;55:2407–2414.
   PubMed Web of Science ®Google Scholar
• Cottet-Maire F, Avdonin PV, Roulet E, Buetler TM, Mermod N, Ruegg UT. Upregulation of vasopressin V-1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment. Br J Pharmacol 2001;132: 909–917.
   Google Scholar
• Krauskopf A, Lhote P, Mutter M, Dufour J-F, Ruegg UT, Buetler TM. Vasopressin type 1A receptor up-regulation by cyclosporin A in vascular smooth muscle cells is mediated by superoxide. J Biol Chem 2003;278: 41685–41690.
   Google Scholar
• Navarro-Antolin J, Lopez-Munoz MJ, Klan P, Soria J, Michel T, Lamas S. Formation of peroxynitrite in vascular endothelial cells exposed to cyclosporine A. FASEB J 2001;15:1291–1293.
   PubMed Web of Science ®Google Scholar
• Navarro-Antolin J, Lopez-Munoz MJ, Soria J, Lamas S. Superoxide limits cyclosporine-A-induced formation of per-oxynitrite in endothelial cells. Free Radic Biol Med 2002;32:702–711.
   PubMedGoogle Scholar
• Chen HW, Chien CT, Yu SL, Lee YT, Chen WJ. Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: Mechanisms via ROS generation, iNOS and Hsp70. Br J Pharmacol 2002;137: 771–781.
   Google Scholar
• Krauskopf A, Buetler TM, Nguyen NSD, Mace K, Ruegg UT Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450. Br J Pharmacol 2002;135:977–986.
   PubMedGoogle Scholar
• Ischiropoulos H, Gow A, Thom SR, Kooy NW, Royall JA, Crow JP. Detection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123. In: Packer L, editor. Methods in Enzymology: Oxygen radicals in biological systems, Part D. San Diego: Academic Press; 1999. p 367–373.
   Google Scholar
• Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: Comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5 (and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhoda-mine 123. Free Radic Biol Med 1999;27: 146–159.
   Google Scholar
• Liochev SI, Fridovich I. Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production. Arch Biochem Biophys 1997;337:115–120.
   PubMed Web of Science ®Google Scholar
• Vasquez-Vivar J, Hogg N, Pritchard Jr, KA, Martasek P, Kalyanaraman B. Superoxide anion formation from lucigenin: An electron spin resonance spin-trapping study. FEBS Lett 1997;403:127–130.
   Google Scholar
• Tsukamoto M, Tampo Y, Yonaha M. Lucigenin reduction by NADPH-cytochrome P450 reductase and the effect of phospholipids and albumin on chemiluminescence. Biochem Mol Biol Int 1998;45: 115–123.
   Google Scholar
• Schepetkin IA. Lucigen in as a substrate of microsomal NAD (P ) H-oxidore ducta s es . Biochem (Mos c .) 1999; 64:25–32.
   PubMedGoogle Scholar
• Tarpey MM, White CR, Suarez E, Richardson G, Radi R, Freeman BA. Chemiluminescent detection of oxidants in vascular tissue. Lucigenin but not coelenterazine enhances superoxide formation. Circ Res 1999;84:1203–1211.
   Google Scholar
• De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RI\4, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase. Circ Res 1998;82: 1094–1101.
   Google Scholar
• Becker LB, vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol 1999;277:H2240–H2246.
   Google Scholar
• Dai X, Galligan jj, Watts SW, Fink GD, Kreulen DL. Increased 02 production and upregulation of ETB receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension 2004;43: 1048–1054.
   Google Scholar
• Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H202 for platelet-derived growth factor signal transduction. Science 1995;270: 296–299.
   Google Scholar
• Wolf A, Clemann N, Frieauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporin-A-mediated impairment of renal functions. Transplant Proc 1994; 26:2902–2907.
   Google Scholar
• Roubaud V, Sankarapandi S, Kuppusamy P, Tordo P, Zweier JL. Quantitative measurement of superoxide generation using the spin trap 5-(diethoxyphosphory1)-5-methy1-1-pyrroline-N-oxide. Anal Biochem 1997;247: 404–411.
   Google Scholar
• Stolze K, Udilova N, Nohl H. Spin trapping of lipid radicals with DEPMPO-derived spin traps: Detection of superoxide, alkyl and alkoxyl radicals in aqueous and lipid phase. Free Radic Biol Med 2000;29:1005–1014.
   Google Scholar
• Miinzel T, Afanas'ev IB, Kleschyov AL, Harrison DG. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol 2002;22:1761–1768.
   PubMedGoogle Scholar
• Siwik DA, Tzortzis JD, Pimental DR, Chang DL-F, Pagano PJ, Singh K, Sawyer DB, Colucci WS. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999;85:147–153.
   Google Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 2000;86:494–501.
   Google Scholar
• Wolin MS, Gupte SA, Oeckler RA. Superoxide in the vascular system. J Vasc Res 2002;39:191–207.
   PubMed Web of Science ®Google Scholar
• Yoshida LS, Abe S, Tsunawaki S. Fungal gliotoxin targets the onset of superoxide-generating NADPH oxidase of human neutrophils. Biochem Biophys Res Commun 2000; 268:716–723.
   Google Scholar
• Van der Pyl D, Inokoshi J, Shiomi K, Yang H, Takeshima H, Omura S. Inhibition of farnesyl-protein transferase by gliotoxin and acetylgliotoxin. J Antibiot 1992;45:1802–1805.
   PubMed Web of Science ®Google Scholar
• Nagase T, Kawata S, Tamura S, Matsuda Y, Inui Y, Yamasaki E, Ishiguro H, Ito T, Miyagawa J, Mitsui H, Yamamoto K, Kinoshita M, Matsuzawa Y. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells. Br J Cancer 1997;76: 1001–1010.
   Google Scholar
• GreenD, Pace SM,HurneAM,WaringP,HartJD,DulhuntyAF. Skeletal muscle ryanodine receptor channels are activated by the fungal metabolite, gliotoxin. J Membr Biol 2000;175:223–233.
   Google Scholar
• Yang JQ, Buettner GR, Domann FE, Li Q, Engelhardt JF, Weydert CD, Oberley LW. v-Ha-ras mitogenic signaling through superoxide and derived reactive oxygen species. Mol Carcinog 2002;33:206–218.
   Google Scholar
• Buetler TM, Cottet-Maire F, Krauskopf A, Ruegg UT. Does cyclosporin A generate free radicals? Trends Pharmac Sci 2000;21:288–290.
   PubMedGoogle Scholar
• Zhong Z, Connor HD, Yin M, Wheeler MD, Mason RP, Thurman RG. Viral delivery of superoxide dismutase gene reduces cyclosporine A-induced nephrotoxicity. Kidney Int 2001;59:1397–1404.
   PubMed Web of Science ®Google Scholar
• Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wang ZQ, Salvemini D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 2003;140:445–460.
   Google Scholar